Investor Birchview Capital, LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Birchview Capital, LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-02-20 13G/A ELUT / Elutia Inc. 1,655,184 1,655,184
2023-04-07 13G/A ELUT / Elutia Inc. 1,515,184 1,655,184
2023-02-13 13G/A ELUT / Elutia Inc. 1,502,123 1,515,184
2022-12-15 13G/A ELUT / Elutia Inc. 1,417,923 1,502,123
2021-12-17 13G AZYO / Aziyo Biologics Inc - Class A 1,417,923 1,417,923
2019-03-19 13G/A SLNO / Soleno Therapeutics, Inc. 1,180,463 742,635
2017-12-29 13D/A YTEN / Yield10 Bioscience, Inc. 2,432,704 352,713
2017-12-26 13G SLNO / Soleno Therapeutics, Inc. 1,180,463
2016-02-16 13G/A HNSN / Hansen Medical, Inc.
2015-06-23 13D/A YTEN / Yield10 Bioscience, Inc. 2,432,704
2015-06-23 13D/A YTEN / Yield10 Bioscience, Inc. 2,432,704
2015-03-19 13G HNSN / Hansen Medical, Inc.